insights_auto
Why is EDIT down 2,34%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
US$1,67
arrow_downward
-2,34%(-0,040) 1D
20 ພ.ຈ., 13 ໂມງ 39 ນາທີ 45 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
US$1,69
High
US$1,78
Low
US$1,66
Mkt. cap
257,75 ລ້ານ
Avg. vol.
2,24 ລ້ານ
Volume
1,09 ລ້ານ
52-wk high
US$3,94
52-wk low
US$1,66
EPS
US$-0,62
Beta
2,09
Shares outstanding
154,34 ລ້ານ
No. of employees
87
Open
US$1,69
High
US$1,78
Low
US$1,66
Mkt. cap
257,75 ລ້ານ
Avg. vol.
2,24 ລ້ານ
Volume
1,09 ລ້ານ
52-wk high
US$3,94
52-wk low
US$1,66
EPS
US$-0,62
Beta
2,09
Shares outstanding
154,34 ລ້ານ
No. of employees
87
News stories
From web sources and news partners
WHEC.com
·
57 ນາທີກ່ອນ
US stocks tumble, and the S&P 500 drops as the sell-off for AI stocks accelerates
WSJ
·
8 ຊົ່ວໂມງກ່ອນ
S&P 500 Flirts With Correction
Adam Feldman | Substack
·
1 ມື້ກ່ອນ
Inside the Federal Litigation of Five S&P 500 Giants
Investor's Business Daily
·
1 ຊົ່ວໂມງກ່ອນ
This VIX Signal Is Bullish For The S&P 500.
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
Foundedພ.ຈ. 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com